Literature DB >> 19520843

Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways.

Lijun Zhou1, Sathyaseelan S Deepa, Julie C Etzler, Jiyoon Ryu, Xuming Mao, Qichen Fang, Dianna D Liu, Jesus M Torres, Weiping Jia, James D Lechleiter, Feng Liu, Lily Q Dong.   

Abstract

The binding of the adaptor protein APPL1 to adiponectin receptors is necessary for adiponectin-induced AMP-activated protein kinase (AMPK) activation in muscle, yet the underlying molecular mechanism remains unknown. Here we show that in muscle cells adiponectin and metformin induce AMPK activation by promoting APPL1-dependent LKB1 cytosolic translocation. APPL1 mediates adiponectin signaling by directly interacting with adiponectin receptors and enhances LKB1 cytosolic localization by anchoring this kinase in the cytosol. Adiponectin also activates another AMPK upstream kinase Ca2+/calmodulin-dependent protein kinase kinase by activating phospholipase C and subsequently inducing Ca2+ release from the endoplasmic reticulum, which plays a minor role in AMPK activation. Our results show that in muscle cells adiponectin is able to activate AMPK via two distinct mechanisms as follows: a major pathway (the APPL1/LKB1-dependent pathway) that promotes the cytosolic localization of LKB1 and a minor pathway (the phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathway) that stimulates Ca2+ release from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520843      PMCID: PMC2755964          DOI: 10.1074/jbc.M109.028357

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  AMP-activated protein kinase in metabolic control and insulin signaling.

Authors:  Mhairi C Towler; D Grahame Hardie
Journal:  Circ Res       Date:  2007-02-16       Impact factor: 17.367

Review 2.  How is AMPK activity regulated in skeletal muscles during exercise?

Authors:  Sebastian Beck Jorgensen; Adam J Rose
Journal:  Front Biosci       Date:  2008-05-01

3.  High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells.

Authors:  Yoshiyuki Hattori; Yasuko Nakano; Sachiko Hattori; Atsuko Tomizawa; Kouichi Inukai; Kiuo Kasai
Journal:  FEBS Lett       Date:  2008-05-01       Impact factor: 4.124

4.  Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

Authors:  Sean L McGee; Kirsty J Mustard; D Grahame Hardie; Keith Baar
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

5.  Ca2+/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation.

Authors:  Carol A Witczak; Nobuharu Fujii; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

Review 6.  The AMP-activated protein kinase: more than an energy sensor.

Authors:  Louis Hue; Mark H Rider
Journal:  Essays Biochem       Date:  2007       Impact factor: 8.000

7.  Thyroid hormone activates adenosine 5'-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-beta.

Authors:  Masako Yamauchi; Fukushi Kambe; Xia Cao; Xiuli Lu; Yasuko Kozaki; Yutaka Oiso; Hisao Seo
Journal:  Mol Endocrinol       Date:  2008-01-10

8.  Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells.

Authors:  Ping Song; Zhonglin Xie; Yong Wu; Jian Xu; Yunzhou Dong; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2008-03-05       Impact factor: 5.157

9.  Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.

Authors:  Zhonglin Xie; Yunzhou Dong; Roland Scholz; Dietbert Neumann; Ming-Hui Zou
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

10.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.

Authors:  Matthew J Sanders; Pascal O Grondin; Bronwyn D Hegarty; Michael A Snowden; David Carling
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

View more
  85 in total

Review 1.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

2.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

3.  APPL1 acts as a protective factor against podocytes injury in high glucose environment.

Authors:  Zhenzhong Ji; Zhengguo Hu; Yancheng Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 4.  Role of adiponectin and some other factors linking type 2 diabetes mellitus and obesity.

Authors:  Chandra Kanti Chakraborti
Journal:  World J Diabetes       Date:  2015-11-10

5.  White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function.

Authors:  Youn Wook Chung; Faiyaz Ahmad; Yan Tang; Steven C Hockman; Hyun Jung Kee; Karin Berger; Emilia Guirguis; Young Hun Choi; Dan M Schimel; Angel M Aponte; Sunhee Park; Eva Degerman; Vincent C Manganiello
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

6.  APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway.

Authors:  Xiaoban Xin; Lijun Zhou; Caleb M Reyes; Feng Liu; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

7.  Adiponectin ameliorates angiotensin II-induced vascular endothelial damage.

Authors:  Zuo Zhi; Zuo Pengfei; Tian Xiaoyi; Ma Genshan
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

8.  Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.

Authors:  Ying Liu; Sanjana Sen; Sivaporn Wannaiampikul; Rengasamy Palanivel; Ruby L C Hoo; Ruth Isserlin; Gary D Bader; Rungsunn Tungtrongchitr; Yves Deshaies; Aimin Xu; Gary Sweeney
Journal:  Biochem J       Date:  2015-04-27       Impact factor: 3.857

9.  Adiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties.

Authors:  Farid Almabouada; Alberto Diaz-Ruiz; Yoana Rabanal-Ruiz; Juan R Peinado; Rafael Vazquez-Martinez; Maria M Malagon
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

10.  Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.

Authors:  Takao Kimura; Hideaki Tomura; Koichi Sato; Masaaki Ito; Isao Matsuoka; Doon-Soon Im; Atsushi Kuwabara; Chihiro Mogi; Hiroshi Itoh; Hitoshi Kurose; Masami Murakami; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.